Eli Lilly and Co. CEO John Lechleiter sits down for his last interview before leaving the drug maker’s top office. He talks about triumphs, the Alzheimer’s disappointment and what’s next for him and wife Sarah as they head into retirement.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}